Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Treatment	Timepoint
LCMS Positive ion mode	Oleoyl Ethanolamide	9.59	nM	Late ITT Infusion Study	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	9.94	nM	GLP1/Late GTT	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	10.2	nM	Early ITT Infusion Study	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	11.2	nM	GLP1/Late GTT	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	12.4	nM	GLP1/Late GTT	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	12.8	nM	GLP1/Late GTT	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	12.9	nM	GLP1/Late GTT	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	12.9	nM	GLP1/Late GTT	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	13	nM	Early ITT Infusion Study	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	13	nM	Late ITT Infusion Study	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	14.4	nM	GLP1/Late GTT	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	14.6	nM	GLP1/Late GTT	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	15.2	nM	Early ITT Infusion Study	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	15.8	nM	GLP1/Late GTT	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	16.4	nM	GLP1/Late GTT	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	16.5	nM	Early ITT Infusion Study	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	16.5	nM	Late ITT Infusion Study	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	16.8	nM	GLP1/Late GTT	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	16.8	nM	Late ITT Infusion Study	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	16.9	nM	GLP1/Late GTT	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	17	nM	GLP1/Late GTT	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	17.5	nM	Early ITT Infusion Study	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	17.9	nM	GLP1/Late GTT	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	18.25	nM	GLP1/Late GTT	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	18.4	nM	Early ITT Infusion Study	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	18.7	nM	GLP1/Late GTT	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	18.8	nM	Late ITT Infusion Study	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	19.1	nM	Early ITT Infusion Study	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	19.1	nM	GLP1/Late GTT	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	19.8	nM	GLP1/Late GTT	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	19.9	nM	Early ITT Infusion Study	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	20.7	nM	GLP1/Late GTT	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	20.8	nM	GLP1/Late GTT	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	20.95	nM	GLP1/Late GTT	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	21	nM	GLP1/Late GTT	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	21	nM	GLP1/Late GTT	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	21.2	nM	GLP1/Late GTT	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	21.7	nM	Early ITT Infusion Study	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	22	nM	Late ITT Infusion Study	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	22.1	nM	GLP1/Late GTT	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	22.3	nM	GLP1/Late GTT	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	22.5	nM	GLP1/Late GTT	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	22.6	nM	Late ITT Infusion Study	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	23	nM	Late ITT Infusion Study	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	23.3	nM	GLP1/Late GTT	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	23.7	nM	GLP1/Late GTT	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	24	nM	GLP1/Late GTT	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	24.4	nM	GLP1/Late GTT	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	24.65	nM	Early ITT Infusion Study	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	24.7	nM	GLP1/Late GTT	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	25.1	nM	Early ITT Infusion Study	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	25.4	nM	Late ITT Infusion Study	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	25.7	nM	Late ITT Infusion Study	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	26	nM	GLP1/Late GTT	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	26.1	nM	GLP1/Late GTT	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	26.2	nM	Early ITT Infusion Study	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	26.2	nM	Late ITT Infusion Study	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	26.3	nM	Late ITT Infusion Study	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	26.5	nM	GLP1/Late GTT	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	26.6	nM	GLP1/Late GTT	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	26.7	nM	Late ITT Infusion Study	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	26.8	nM	Early ITT Infusion Study	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	27.3	nM	Early ITT Infusion Study	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	27.6	nM	GLP1/Late GTT	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	27.8	nM	Early ITT Infusion Study	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	27.8	nM	GLP1/Late GTT	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	28	nM	GLP1/Late GTT	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	28.1	nM	Early ITT Infusion Study	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	28.5	nM	Early ITT Infusion Study	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	28.6	nM	Early ITT Infusion Study	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	28.8	nM	GLP1/Late GTT	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	29	nM	GLP1/Late GTT	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	29.1	nM	Late ITT Infusion Study	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	29.4	nM	Late ITT Infusion Study	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	29.7	nM	Early ITT Infusion Study	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	29.9	nM	GLP1/Late GTT	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	30.2	nM	Early ITT Infusion Study	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	30.6	nM	Late ITT Infusion Study	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	31	nM	Early ITT Infusion Study	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	31.5	nM	GLP1/Late GTT	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	31.5	nM	Late ITT Infusion Study	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	31.9	nM	GLP1/Late GTT	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	31.9	nM	GLP1/Late GTT	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	31.9	nM	GLP1/Late GTT	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	32.1	nM	GLP1/Late GTT	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	33	nM	GLP1/Late GTT	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	34.3	nM	GLP1/Late GTT	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	34.3	nM	Late ITT Infusion Study	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	34.3	nM	Late ITT Infusion Study	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	34.5	nM	GLP1/Late GTT	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	34.8	nM	Late ITT Infusion Study	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	35	nM	Late ITT Infusion Study	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	35.3	nM	GLP1/Late GTT	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	35.3	nM	GLP1/Late GTT	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	35.9	nM	Early ITT Infusion Study	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	36.4	nM	Late ITT Infusion Study	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	37.1	nM	Early ITT Infusion Study	30 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	37.8	nM	GLP1/Late GTT	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	40.1	nM	GLP1/Late GTT	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	40.4	nM	Early ITT Infusion Study	120 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	42.8	nM	GLP1/Late GTT	0 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	43.5	nM	Late ITT Infusion Study	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	43.8	nM	Late ITT Infusion Study	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	44.7	nM	GLP1/Late GTT	60 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	52.3	nM	GLP1/Late GTT	10 mins
LCMS Positive ion mode	Oleoyl Ethanolamide	53.5	nM	GLP1/Late GTT	0 mins